← Back
$ADPT All transactions

Adaptive Biotechnologies Corp

▼ SELL

$ Value

$3K

Shares

238

Price

$14

Filed

Nov 18

Insider

Name

PISKEL KYLE

Title

Chief Financial Officer

CIK

0001780662

Roles

Officer

Transaction Details

Transaction Date

2025-11-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

269,343

Footnotes

This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Filing Info

Accession No.

0001780662-25-000002

Form Type

4

Issuer CIK

0001478320

PISKEL KYLE's History

Date Ticker Type Value
2026-03-04 ADPT A $0
2026-02-04 ADPT M $26K
2026-02-04 ADPT $40K
2026-02-04 ADPT M $0
2026-01-12 ADPT M $52K
2026-01-12 ADPT $77K
2026-01-12 ADPT M $0
2025-11-28 ADPT M $78K
2025-11-28 ADPT M $29K
2025-11-28 ADPT M $1.1M

Other Insiders at ADPT (90d)

Insider Bought Sold Last
GRIFFIN MICHELLE RENEE $735K 2026-03-04
NEUPERT PETER M 2026-03-04
HERSHBERG ROBERT 2026-03-04
ROBINS CHAD M
CEO and Chairman
$12.4M 2026-04-08
LO FRANCIS
Chief People Officer
$915K 2026-04-08
PISKEL KYLE
Chief Financial Officer
$40K 2026-03-04
RUBINSTEIN JULIE
President and COO
$7.2M 2026-04-21
ROBINS HARLAN S
Chief Scientific Officer
$1.3M 2026-04-08
BENZENO SHARON
Chief Commercial Ofc Imm Med
2026-03-04
BOBULSKY SUSAN
Chief Commercial Officer, MRD
2026-03-04
OWEN KATEY EINTERZ 2026-03-04